Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Haleon plc
  6. Summary
    HLN   GB00BMX86B70

HALEON PLC

(HLN)
  Report
Delayed London Stock Exchange  -  11:35 2022-12-09 am EST
314.60 GBX   -0.49%
05:00pWeekly market update : Waiting for Jay
MS
11:40aPUMP / DUMP #54 : This week's gainers and losers
MS
12/07LONDON MARKET CLOSE: Pharma stocks fail to lift FTSE 100 in the green
AN
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
12/05/2022 12/06/2022 12/07/2022 12/08/2022 12/09/2022 Date
295(c) 295.2(c) 305.7(c) 316.15(c) 314.6(c) Last
12 992 320 6 921 897 38 850 137 16 041 122 11 699 084 Volume
+1.22% +0.07% +3.56% +3.42% -0.49% Change
More quotes
Estimated financial data (e)
Sales 2022 10 861 M 13 360 M 13 360 M
Net income 2022 1 469 M 1 807 M 1 807 M
Net Debt 2022 10 094 M 12 417 M 12 417 M
P/E ratio 2022 20,2x
Yield 2022 1,00%
Sales 2023 11 584 M 14 250 M 14 250 M
Net income 2023 1 740 M 2 141 M 2 141 M
Net Debt 2023 8 726 M 10 734 M 10 734 M
P/E ratio 2023 16,4x
Yield 2023 2,08%
Capitalization 29 052 M 35 737 M 35 737 M
EV / Sales 2022 3,60x
EV / Sales 2023 3,26x
Nbr of Employees 22 000
Free-Float 61,5%
More Financials
Company
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (28.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.4%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health... 
Sector
Pharmaceuticals
Calendar
03/23Earnings Release
More about the company
All news about HALEON PLC
05:00pWeekly market update : Waiting for Jay
MS
11:40aPUMP / DUMP #54 : This week's gainers and losers
MS
12/07LONDON MARKET CLOSE: Pharma stocks fail to lift FTSE 100 in the gree..
AN
12/07LONDON MARKET MIDDAY: Stocks slide amid risk-off mood after China d..
AN
12/07Barclays Lifts Haleon to Overweight from Equalweight, Hikes PT
MT
12/07LONDON BROKER RATINGS: Jefferies cuts PageGroup but keeps Hays at ..
AN
12/07FTSE Gains as GSK Rallies on Favorable Court Ruling
DJ
12/07GSK, Sanofi shares brighten as thousands of Zantac lawsuits are dismissed
RE
12/07Sanofi, GSK Shares Jump After Zantac Lawsuit Dismissal
DJ
12/07LONDON MARKET OPEN: Pharmaceutical stocks led by GSK spare FTSE 100
AN
12/07LONDON BRIEFING: Stocks called flat on mixed news from China
AN
12/06TOP NEWS: GSK welcomes Zantac legal boost in Florida
AN
11/22A December rally seems less and less likely...
MS
11/22Lucy Launches Inaugural Customer Advisory Board
AQ
11/22Analyst recommendations: Activision, BP, HubSpot, Procter & Gamb..
MS
More news
News in other languages on HALEON PLC
05:00pLe point hebdo de l'investisseur : En attendant Jay
05:00pEl boletín semanal del inversor : A la espera de Jay
11:40aPUMP / DUMP #2: Los Tops & Flops de la semana
10:53aPUMP / DUMP #84 : Les Tops & Flops de la semaine
12/07LATE BRIEFING - Unternehmen und Märkte
More news
Analyst Recommendations on HALEON PLC
More recommendations
ETFs positioned on HALEON PLCETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
First Trust IPOX Europe Equity Opportunitie...4.51%-2.15%-NC
First Trust IPOX Europe Equity Opportuniti...4.51%-1.99%Europe
First Trust International IPO ETF - USD2%-1.36%World
SPDR MSCI Europe Consumer Staples - EUR1.43%-2.42%-NC
IShares MSCI Europe Consumer Staples Sector...1.41%-2.31%-NC
More ETFs positioned on HALEON PLC
Chart HALEON PLC
Duration : Period :
Haleon plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HALEON PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 314,60 GBX
Average target price 330,07 GBX
Spread / Average Target 4,92%
EPS Revisions
Managers and Directors
Brian James McNamara Chief Executive Officer & Executive Director
Tobias Hannes Hestler Chief Financial Officer & Executive Director
David John Lewis Non-Executive Chairman
Amy Landucci Head-Digital & Technology
Franck Riot Head-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
HALEON PLC0.00%35 683
JOHNSON & JOHNSON3.57%463 286
ELI LILLY AND COMPANY34.66%353 267
ABBVIE INC.22.59%293 450
PFIZER, INC.-14.92%290 657
NOVO NORDISK A/S22.08%287 434